Zimmer Biomet Holdings Inc
NYSE:ZBH
Zimmer Biomet Holdings Inc
Cash Equivalents
Zimmer Biomet Holdings Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zimmer Biomet Holdings Inc
NYSE:ZBH
|
Cash Equivalents
$393m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash Equivalents
$1.2B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash Equivalents
$2.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
76%
|
CAGR 10-Years
28%
|
|
Stryker Corp
NYSE:SYK
|
Cash Equivalents
$2.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash Equivalents
$6.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash Equivalents
$2.2B
|
CAGR 3-Years
39%
|
CAGR 5-Years
29%
|
CAGR 10-Years
11%
|
See Also
What is Zimmer Biomet Holdings Inc's Cash Equivalents?
Cash Equivalents
393m
USD
Based on the financial report for Mar 31, 2024, Zimmer Biomet Holdings Inc's Cash Equivalents amounts to 393m USD.
What is Zimmer Biomet Holdings Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-8%
Over the last year, the Cash Equivalents growth was 19%. The average annual Cash Equivalents growth rates for Zimmer Biomet Holdings Inc have been -18% over the past three years , -8% over the past five years , and -8% over the past ten years .